Exercise 3-4 Flashcards
1
Q
Comparison of community pharmacy in 1990’s and 2000’s
A
- location
- signboards
- store front and interiors
- staffing pattern
- pharmacist
- communication
- store facilities
- capitalization
- transportation
2
Q
General guidelines for establishing pndf
A
Relevance to disease Efficacy and safety Quality Cost Appropriateness to capability of health workers at different levels of health care Local health problems Benefit/risk ratio Preferential factors for evaluating therapeutically equivalent drugs Drugs formulated as single compounds Period review of drug list
3
Q
Criteria for inclusion of drugs into pndf
A
- drug is needed for prevention and tx of conditions not already covered in existing list
- drug is more effective/less toxic than the drug listed for same medication
- drug is at least as effective and safe and of lower cot than the drug listed for the same indication
- drug is essential for specific DOH health project
4
Q
Criteria for deletion of drugs from pndf
A
- more or equally effective but less toxic drug becomes available
- therapeutic efficacy of drug is found to be unsatisfactory or questionable
- toxicity/ suspended toxicity or potential abuse or dangerous interactions outweigh its therapeutic value
- disease of drug and no longer available
- drug is no longer deemed cost-effective to other therapies
- drug is fixed dose combination which does not satisfy req. of AO of s. 1990
5
Q
Dangerous drugs
A
Alprazolam Bromazepam Butorphanol Clonazepam Codein Diazepam Methylphenidate Midazolam Morphine Nalbuphine Oxycodone Pethidine ( meperidine ) Phenobarbital Thiopental Na Tramadol Zolpidem
6
Q
Controlled precursors and essential chemicals (A2)
A
Ephedrine
Ergotamine
PPA
7
Q
Medicinal products listed with bfad
A
Akapulko Lagundi Sambong Tsaang gubat Yerba buena
8
Q
Ways of developing competitive advantages in community pharmacy
A
- product line assortment
- leader pricing strategy
- innovation of operation
- customer services
- equipment/facilities
